Home > News > Eiffel to accelerate drug re-engineering efforts
June 3rd, 2004
Eiffel to accelerate drug re-engineering efforts
Eiffel said it plans to use its Supercritical Fluid (SCF) technology, designed to improve the efficacy of drugs and extend their patent life by reforming them into nano-sized particles that are easier for the body to absorb, in the area of asthma.
Sopping up proteins with thermosponges: Researchers develop novel nanoparticle platform that proves effective in delivering protein-based drugs October 22nd, 2014
Bipolar Disorder Discovery at the Nano Level: Tiny structures found in brain synapses help scientists better understand disorder October 22nd, 2014
Journal Nanotechnology Progress International (JONPI), 2014, Volume 5, Issue 1, pp 1-24 October 22nd, 2014
TARA Biosystems and Harris & Harris Group Form Company to Improve Safety and Efficacy of New Therapies October 22nd, 2014